The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERON PHARMA INC | COM | 00434H108 | 5,757 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 686 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 3,730 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
ARYA SCIENCES ACQUISITION CO | COM CL A | G3166W106 | 3,255 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 1,668 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ATHENEX INC | COM | 04685N103 | 2,212 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 2,037 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 815 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 1,144 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BEYONDSPRING INC | SHS | G10830100 | 915 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 11,022 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 663 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM | 15117B202 | 1,314 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HOLDINGS I | *W EXP 06/09/2025 | 15678U102 | 409 | 72,466 | SH | SOLE | 72,466 | 0 | 0 | ||
CEREVEL THERAPEUTICS HOLDINGS I | COM | 15678U128 | 4,477 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
CHARDAN HEALTHCARE ACQUISITION 2 CORP | COM | 15957T107 | 794 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 2,379 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 536 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | ||
CURIS INC | COM | 231269200 | 11,876 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 918 | 117,545 | SH | SOLE | 117,545 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 1,455 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 881 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 29,606 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 2,166 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
HEALTH SCIENCES ACQUISITIONS CORP 2 | ORD SHS | G4411D109 | 2,562 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 3,292 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/2025 | N44445117 | 699 | 242,855 | SH | SOLE | 242,855 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 3,464 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
INARI MEDICAL INC | COM | 45332Y109 | 873 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 909 | 19,600 | SH | SOLE | 19,600 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 855 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 8,492 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 2,035 | 904,600 | SH | SOLE | 904,600 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 3,201 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP | COM CL A | 543195101 | 1,484 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 570 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 556 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
MEIRAGTX HOLDINGS PLC | COM | G59665102 | 1,514 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 2,238 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,331 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 2,196 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 2,265 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 4,554 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
OUTSET MEDICAL INC | COM | 690145107 | 568 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
PANDION THERAPEUTICS INC | COM | 698340106 | 1,188 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
PULMONX CORPORATION | COM | 745848101 | 1,380 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
RETROPHIN INC | NOTE 2.500 9/15/2025 | 761299AB2 | 4,035 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,758 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 695 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 1,895 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
SPDR S&P 500 ETF TRUST TRUST | TR UNIT | 78462F103 | 14,955 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
SUTRO BIOPHARMA INC | COM | 869367102 | 4,342 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,347 | 150,500 | SH | Call | SOLE | 150,500 | 0 | 0 | |
VAXART INC | COM NEW | 92243A200 | 143 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
VAXCYTE INC | COM | 92243G108 | 797 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 2,363 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
VESPER HEALTHCARE ACQUISITION CORP | COM CL A | 92538T104 | 1,131 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VESPER HEALTHCARE ACQUISITION CORP | *W EXP 09/30/2027 | 92538T112 | 88 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
VINCERA PHARMA INC | COM | 92731L106 | 8,427 | 403,000 | SH | SOLE | 403,000 | 0 | 0 | ||
VINCERA PHARMA INC | *W EXP 12/24/2025 | 92731L114 | 627 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 3,072 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 44 | 13,285 | SH | SOLE | 13,285 | 0 | 0 |